5-(Trifluoromethyl)-1-benzothiophene-2-carboxylic acid, 95.0%, 250mg

Gamma-glutamylcysteine, 98%, 50mg

1-ETHYL-1H-IMIDAZOLE-4-CARBOXYLIC ACID, 95.0%, 250mg

2-BROMO-5,8-DIOXASPIRO[3.4]OCTANE, 95.0%, 25g

Cumene>99.0%(GC)500mL

5-(Trifluoromethyl)benzo[d]oxazol-2(3H)-one, 98%, 1g

4-Methyl-5-trifluoromethyl-2-(3-fluoro-phenyl)-thiazole, 1g

N-3-Butyn-1-ylcyclopentanamine, 95%, 5g

4-(((2S,4S)-1-([1,1'-BIPHENYL]-4-YL)-5-ETHOXY-4-METHYL-5-OXOPENTAN-2-YL)AMINO)-4-OXOBUTANOIC ACID, 98%, 5mg

4-((6-AMINOPYRIMIDIN-4-YL)AMINO)BENZENESULFONAMIDE HYDROCHLORIDE, 95%, 100mg

Condensador Abbe 1,25 NA con apertura para campo oscuro y corredera de contraste de fases. Sin diapositivas de campo oscuro y sin diapositivas de contraste de fase

4-Bromo-1,3-thiazole-2-carboxylic acid, 96.0%, 250mg

2-((2R,3R)-3-(tert-butyl)-4(2,6-dimethoxyphenyl)-2,3dihydrobenzo[d][1,3]oxaphosphol-2-yl)pyridine, 97%, 500mg